Pharmaco - Press Releases

Date	Title	Company
31-May-2023	M1 Kliniken AG publishes Q1 figures 2023: Strong growth and disproportionate increase in operating result	M1 Kliniken AG
31-May-2023	HAEMATO AG with a strong start into the year 2023: Revenue increase of over 25% compared to the same quarter of the previous year and disproportionate increase in the operating result	HAEMATO AG
31-May-2023	Evaxion Announces Business Update and First Quarter 2023 Financial Results	Evaxion
31-May-2023	Biognosys Launches Spectronaut 18 and Presents Advances in Proteomics Depth, Sensitivity, and Scalability at the ASMS 2023 Annual Conference	Biognosys
31-May-2023	Violet Therapeutics raises $10.6 million in seed funding led by the Dementia Discovery Fund (through DDF-2) and co-led by UTEC (University of Tokyo Edge Capital Partners) and Mass General Brigham Ventures (MGBV)	Violet Therapeutics
31-May-2023	Global Obesity Drugs Sales Could Top $44 Billion in 2030, says Bloomberg Intelligence	Bloomberg Intelligence
31-May-2023	Major breakthrough in bacteriophage research launches start-up to solve infection crisis	PHIOGEN
31-May-2023	Medios AG: Supervisory Board extends contract with Chief Financial Officer Falk Neukirch	Medios AG
31-May-2023	PRECISION ONCOLOGY OFFERS FUTURE PROSPECTS FOR BILIARY TRACT CANCER	PRECISION ONCOLOGY
31-May-2023	New number of shares and votes in Moberg Pharma AB (publ)	Moberg Pharma AB
31-May-2023	Anocca raises SEK 400 million for large-scale development of cancer cell therapies	Anocca
31-May-2023	Kinarus Therapeutics Group Reports 2022 Annual Results	Kinarus Therapeutics
31-May-2023	4,000-year-old plague DNA found – the oldest cases to date in Britain	Francis Crick Institute
31-May-2023	Mainz Biomed Expands Commercial Footprint into Poland	Mainz BioMed N.V.
31-May-2023	Orthonika awarded £1.34 million Innovate UK grant to accelerate development of its total meniscus replacement towards the clinic	Sciad Newswire
31-May-2023	Epigenomics AG Reports Financial Results for the First Quarter of 2023	Epigenomics AG
31-May-2023	Vita 34 successfully implements price increases in first quarter of 2023 in generally weak market environment	Vita 34 AG
31-May-2023	Kinarus Therapeutics Group Reports 2022 Annual Results	Kinarus Therapeutics Holding AG
30-May-2023	OLON Enters in ADC Market	OLON
30-May-2023	eXmoor pharma completes USD 35 million Series A to expand cell and gene therapy manufacturing capabilities	eXmoor pharma